Orakl Oncology combines data and biology to bring new drugs to cancer patients
Cancer incidence is on the rise, particularly among younger adults, but most new drug compounds fail to progress through clinical trials. According to French entrepreneur Fanny Jaulin (on the right in the picture above), the problem lies with clinical trial design. “Just because a drug isn’t successful in clinical trials doesn’t mean it’s not a […]
© 2024 TechCrunch. All rights reserved. For personal use only.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
